Arcellx Inc (ACLX)
87.22
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
87.15
-0.07
(-0.08%)
After-Hours: 20:00
Arcellx Profit Margin (Quarterly): -99.37% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -99.37% |
| June 30, 2024 | -99.34% |
| March 31, 2024 | -18.34% |
| December 31, 2023 | 31.42% |
| Date | Value |
|---|---|
| September 30, 2023 | -263.0% |
| June 30, 2023 | -166.8% |
| March 31, 2023 | -152.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-263.0%
Minimum
Sep 2023
31.42%
Maximum
Dec 2023
-109.7%
Average
-99.37%
Median
Sep 2024
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| AbbVie Inc | 10.80% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -9.11% |
| Return on Assets | -5.44% |
| Return on Invested Capital | -9.11% |
| Operating Margin (Quarterly) | -129.1% |
| Return on Net Operating Assets | -49.35% |